Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Adagio Therapeutics, Inc. | Other*, 10%+ Owner | Common Stock | 11.2M | $44.4M | $3.95 | Mar 28, 2022 | Direct |
Adagio Therapeutics, Inc. | Other*, 10%+ Owner | Series A Preferred Stock | 0 | Aug 10, 2021 | Direct | ||
Adagio Therapeutics, Inc. | Other*, 10%+ Owner | Series B Preferred Stock | 0 | Aug 10, 2021 | Direct | ||
Adagio Therapeutics, Inc. | Other*, 10%+ Owner | Series C Preferred Stock | 0 | Aug 10, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IVVD | Adagio Therapeutics, Inc. | Mar 28, 2022 | 0 | $0 | 4 | Mar 30, 2022 | Other*, 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 10, 2021 | 5 | $33.9M | 4 | Aug 12, 2021 | 10%+ Owner |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3/A | Aug 12, 2021 | 10%+ Owner |